ABT - Abbott Laboratories

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
146.32B
Enterprise Value 3
161.44B
Trailing P/E
50.92
Forward P/E 1
22.93
PEG Ratio (5 yr expected) 1
2.20
Price/Sales (ttm)
4.73
Price/Book (mrq)
4.62
Enterprise Value/Revenue 3
5.22
Enterprise Value/EBITDA 6
21.45

Trading Information

Stock Price History

Beta (3Y Monthly) 0.80
52-Week Change 320.23%
S&P500 52-Week Change 38.78%
52 Week High 388.76
52 Week Low 365.44
50-Day Moving Average 382.58
200-Day Moving Average 381.81

Share Statistics

Avg Vol (3 month) 34.51M
Avg Vol (10 day) 35.86M
Shares Outstanding 51.77B
Float 1.75B
% Held by Insiders 10.72%
% Held by Institutions 176.49%
Shares Short (Sep 30, 2019) 416.86M
Short Ratio (Sep 30, 2019) 44.22
Short % of Float (Sep 30, 2019) 40.98%
Short % of Shares Outstanding (Sep 30, 2019) 40.95%
Shares Short (prior month Aug 30, 2019) 415.42M

Dividends & Splits

Forward Annual Dividend Rate 41.28
Forward Annual Dividend Yield 41.57%
Trailing Annual Dividend Rate 31.24
Trailing Annual Dividend Yield 31.51%
5 Year Average Dividend Yield 42.00
Payout Ratio 474.07%
Dividend Date 3Nov 15, 2019
Ex-Dividend Date 4Jul 12, 2019
Last Split Factor (new per old) 24798/10000
Last Split Date 3Jan 2, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 9.36%
Operating Margin (ttm)14.37%

Management Effectiveness

Return on Assets (ttm)4.06%
Return on Equity (ttm)9.21%

Income Statement

Revenue (ttm)30.93B
Revenue Per Share (ttm)17.54
Quarterly Revenue Growth (yoy)2.70%
Gross Profit (ttm)17.92B
EBITDA 7.53B
Net Income Avi to Common (ttm)2.87B
Diluted EPS (ttm)1.63
Quarterly Earnings Growth (yoy)37.20%

Balance Sheet

Total Cash (mrq)3.38B
Total Cash Per Share (mrq)1.91
Total Debt (mrq)20.07B
Total Debt/Equity (mrq)62.92
Current Ratio (mrq)1.68
Book Value Per Share (mrq)17.93

Cash Flow Statement

Operating Cash Flow (ttm)5.72B
Levered Free Cash Flow (ttm)3.87B